On July 11, 2012, Merus Labs International Inc. acquired Emselex®/Enablex®. Stewart Muglich and Victor Dudas of our Corporate Finance & Securities Group handled the debt facility between Merus and PDL BioPharma Inc., a company that supports the healthcare industry with creative financing solutions, assisted by Amaan Gangji and Kevin MacDonald. The transaction involved counsel from Toronto, New York, Switzerland, the Netherlands and Luxembourg.
Related Content
BC Franchises Act and Regulations
On October 3, 2016, the Franchises Act and related regulations were approved by the BC provincial cabinet. Although the act and its regulations are now ... Continued
Brendan Morley presenting at upcoming TLABC seminar
Brendan Morley will be presenting at a TLABC seminar next Friday on the topic of Equitable Doctrines, Defences and Remedies. This is a terrific learning opportunity ... Continued
SFU’s Impact
SFU is where progressive education, research and community outreach intersect, evidenced by its consistent ranking as one of Canada’s top comprehensive universities. They have supported ... Continued